XML 29 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation
 6 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION:
The following table summarizes the share-based compensation expense and related information for Time-Based Options ("TBOs"), Retention Time-Based Options ("TBO-Rs"), Time-Based Restricted Stock Units ("RSUs"), Performance Stock Units ("PSUs"), Deferred Stock Units and Employee Stock Purchase Plan ("ESPP") recorded within "Selling and general corporate expenses" on the Condensed Consolidated Statements of Income (in millions).
Three Months EndedSix Months Ended
March 31, 2023April 1, 2022March 31, 2023April 1, 2022
TBOs$3.9 $3.8 $7.6 $8.2 
TBO-Rs1.2 1.1 3.1 2.4 
RSUs13.2 14.3 26.8 29.4 
PSUs2.3 1.2 4.4 2.8 
Deferred Stock Units0.5 0.5 0.8 1.0 
ESPP(1)
— 2.3 2.4 4.1 
$21.1 $23.2 $45.1 $47.9 
Taxes related to share-based compensation$3.9 $4.1 $8.1 $8.7 
Cash Received from Option Exercises/ESPP Purchases4.5 12.0 34.1 23.7 
Tax (Provision) Benefit on Share Deliveries(0.1)0.2 0.4 0.1 
(1)
The Company temporarily suspended its ESPP beginning in the second quarter of fiscal 2023.
The below table summarizes the number of shares granted and the weighted-average grant-date fair value per unit during the six months ended March 31, 2023:
Shares Granted
(in millions)		Weighted Average Grant-Date Fair Value
(dollars per share)
TBOs(1)
0.9 $17.01 
RSUs(1)
1.3 $40.27 
PSUs(1)(2)
0.5 $48.88 
2.7 
(1)
The Company's annual grants for fiscal 2023 were awarded in November 2022 and will vest based upon continued employment over four years. All TBOs remain exercisable for 10 years from the date of grant.
(2)
During the first quarter of fiscal 2023, the Company granted PSUs subject to the level of achievement of adjusted revenue growth, cumulative adjusted earnings per share, return on invested capital and relative total shareholder return for the cumulative performance period over three years and the participant's continued employment with the Company over four years. The Company is accounting for a portion of the award as a performance-based award, with the grant-date fair value based on the fair value of the Company's common stock. The Company is accounting for the remainder of the award as a market-based award valued utilizing the Monte Carlo Simulation pricing model, which calculates multiple potential outcomes for an award and establishes fair value based on the most likely outcome.